Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Virax Biolabs Group Ltd VRAX

Virax Biolabs Group Limited is a biotechnology company. The Company is primarily engaged in the sales, distribution and marketing of diagnostics test kits and medical technology for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. It is developing a T-Cell Test technology with the intention of providing an... see more

Recent & Breaking News (NDAQ:VRAX)

Virax Biolabs to Participate at ESCMID Global 2024

PR Newswire 2 days ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

PR Newswire March 15, 2024

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

PR Newswire December 21, 2023

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

PR Newswire December 18, 2023

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

PR Newswire December 14, 2023

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

PR Newswire September 12, 2023

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

PR Newswire September 1, 2023

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

PR Newswire August 3, 2023

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

PR Newswire July 18, 2023

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

PR Newswire June 14, 2023

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

PR Newswire May 4, 2023

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

PR Newswire April 19, 2023

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

PR Newswire March 10, 2023

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

PR Newswire March 8, 2023

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

PR Newswire March 7, 2023

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

PR Newswire February 7, 2023

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

PR Newswire February 6, 2023

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

PR Newswire February 2, 2023

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

PR Newswire January 4, 2023

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

PR Newswire December 6, 2022